Vivos wins FDA clearance to launch Mayo Clinic feasibility study for RadioGel thyroid cancer therapy

Reuters2026/07/27 18:47

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vivos received FDA clearance on July 22, 2026 for a Feasibility IDE to start a first-in-human study at Mayo Clinic in Jacksonville.
Initial enrollment set at 5 patients with non-resectable papillary thyroid carcinoma to assess safety and feasibility.
FDA shortened the required safety follow-up to 24 months from 5 years, cutting the period by about 60%.
Veterinary IsoPet network expanded to 17 certified US clinics, treating more than 200 small animals and horses.
Validation work at the Richland, Washington facility neared completion; shipments for veterinary use targeted by quarter-end.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Inc. published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vivos wins FDA clearance to launch Mayo Clinic feasibility study for RadioGel thyroid cancer therapy

You may also like

Crypto prices